Skip to Content Facebook Feature Image

KANEKA UBIQUINOL™ AWARDED PRESTIGIOUS COMPLEMENTARY MEDICINES AUSTRALIA RAW MATERIAL SUPPLIER OF THE YEAR AWARD 2024

Business

KANEKA UBIQUINOL™ AWARDED PRESTIGIOUS COMPLEMENTARY MEDICINES AUSTRALIA RAW MATERIAL SUPPLIER OF THE YEAR AWARD 2024
Business

Business

KANEKA UBIQUINOL™ AWARDED PRESTIGIOUS COMPLEMENTARY MEDICINES AUSTRALIA RAW MATERIAL SUPPLIER OF THE YEAR AWARD 2024

2024-12-06 06:10 Last Updated At:06:25

SYDNEY, Dec. 6, 2024 /PRNewswire/ -- Kaneka Ubiquinolâ„¢ has been awarded the coveted Raw Material Supplier of the Year Award 2024 at the Complementary Medicines Australia (CMA) Awards, held in Sydney this evening.

This prestigious accolade recognises Kaneka Ubiquinol's exceptional contribution to advancing the complementary medicines industry through innovation, scientific rigour, and an unparalleled commitment to quality.

Kaneka Ubiquinol is dedicated to advancing the science of healthy ageing through its unique ingredient, bioidentical Ubiquinol. Supported by 100+ studies, 80+ global patents, and 45+ years of cutting-edge research, Kaneka Ubiquinol continues to lead the field. This commitment was recently acknowledged at the Nutraingredients-Asia Awards in Bangkok where they were the recipient of the Healthy Ageing Ingredient of the Year 2024 Award.  

These awards are testament to Kaneka Ubiquinol's exemplary commitment to research and development, best-in-class precision Japanese manufacturing, and stringent quality control. Moreover, they are representation of their devotion to providing innovative solutions that support mitochondrial health, cardiovascular health, cognition, women's health, fertility, energy production, and overall wellbeing for healthy ageing.

"We are deeply honoured for Kaneka Ubiquinolâ„¢ to be named the recipient of the prestigious CMA Raw Material Supplier of the Year Award 2024," said Tsuyoshi Takakuwa, Head of Marketing and Sales Supplement Division APAC, Kaneka Corporation, Japan.

"Australia sets the highest benchmark in excellence in complementary medicines globally, and this award is one of the greatest industry accolades we could receive, for our entire team across R&D, manufacturing, distribution, and marketing," Takakuwa said.

Kazuki Takita, Sales and Marketing Head for Kaneka Ubiquinol APAC, based in Tokyo, Japan, emphasised the company's dedication to operational excellence and building long-standing partnerships.

"This achievement recognises the hard work of our teams across the region, the trust of our partners, and the loyalty of consumers who rely on Kaneka Ubiquinol as part of their health journeys."

He continued, "We are proud to work closely with contract manufacturers to achieve superior outcomes, supported by transparent communication and sustained scientific and operational support."

"We extend our gratitude to Complementary Medicines Australia and the awards committee for this recognition, as well as to our partners and supporters. It is an honour to share this moment with other industry leaders who are also advancing health and innovation. Congratulations to all award winners," Takita said.

The CMA Raw Material Supplier of the Year Award celebrates excellence in the complementary medicines sector, recognising top innovations, products, and services that drive industry progress. Winning this award is a significant achievement that underscores Kaneka Ubiquinol as a global leader in delivering high-quality raw materials, empowering brands and practitioners to promote health and vitality through exceptional innovation and reliability.

ABOUT UBIQUINOL
Ubiquinol is a potent, lipid-soluble antioxidant found naturally in the mitochondria within all cells in the body. It fuels these organelles to generate energy (ATP) for the entire body and helps protect the body's cells from damage caused by free radicals, maintaining optimal health.

Ubiquinol levels in the mitochondria naturally decline after the age of 20, as the body's endogenous production decreases and cells are exposed to higher levels of oxidative stress. This impacts energy production, mitochondrial health, and various body systems.

ABOUT KANEKA UBIQUINOLâ„¢
Japan's Kaneka Corporation is the sole global supplier of world-class scientifically formulated Kaneka Ubiquinolâ„¢, supported by 100+ scientific studies, 80+ patents and 45+ years of research for mitochondrial health, cardiovascular health, fertility and energy production. Since 2022, it is now listed in over 50 countries in 500 practitioner and OTC nutraceutical brands. Kaneka Ubiquinolâ„¢ is the recipient of the Annual Ingredient Cardiovascular Health Award 2024 by Functional Foods for Wellness Summit (FFWS), as well as being a finalist in the Healthy Ageing category of the NutraIngredients-Asia Awards for 2024. 

www.ubiquinol.net.au

** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **

KANEKA UBIQUINOL™ AWARDED PRESTIGIOUS COMPLEMENTARY MEDICINES AUSTRALIA RAW MATERIAL SUPPLIER OF THE YEAR AWARD 2024

KANEKA UBIQUINOL™ AWARDED PRESTIGIOUS COMPLEMENTARY MEDICINES AUSTRALIA RAW MATERIAL SUPPLIER OF THE YEAR AWARD 2024

Next Article

Japan Global Innovators' Forum 2025

2024-12-26 18:12 Last Updated At:18:35

The annual meeting is returning for its second year after a successful inaugural event in 2024

TOKYO, Dec. 26, 2024 /PRNewswire/ -- Tokyo-based global media agency Pacific Bridge Media and Consulting Inc. (PBMC) is pleased to announce that the 2nd annual Japan Global Innovators' Forum (JGIF) will be held in March 2025. PBMC's solutions-focused multilingual news service J-Stories will co-host the event with the Mainichi national daily's startup accelerator, Mainichi Future Creation Lab.

Innovative Japanese and international startups with global ambitions will gather in the heart of Tokyo on March 13, showcasing the solutions they offer to address the world's biggest social and environmental challenges. A panel of industry experts will assess their growth potential both in Japan and abroad at the cross-border pitch event.

Participating startups in the 2025 event will include not only Japanese startups aiming to expand into global markets, but also ambitious inbound Asian startups that are taking on the challenge of solving some of Japan's critical problems — such as its aging population and rural depopulation.

The categories to be focused on are Age Tech, Health Tech, Mobility, and Green Energy. There will also be special sessions featuring East Asian startups as well as Japan's regional startups.

Organizers hope that the event will provide practical opportunities for participating entrepreneurs to meet potential partners and supporters in Japan and overseas, including venture capitalists and corporate venture capitalists, among other startup ecosystem players.

Details of the event will be unveiled on a special page in J-Stories by the end of January.

The inaugural Japan Global Innovators' Forum, a pioneering English-language startup event that promoted dialogue between innovators in Japan and their potential supporters overseas, was held in March of this year at the Tokyo Innovation Base in central Tokyo and live-streamed globally. The event highlighted Japan-based social entrepreneurs aiming to scale globally while offering solutions to social and environmental challenges commonly shared across the world.

Event report: https://jstories.media/article/jgif-event-release

[Event Overview]

"2nd Japan Global Innovators' Forum"

Date: Thursday, March 13, 2025

Time: 1-6 p.m. (Subject to change), followed by a networking event

Venue: Mainichi Hall (Located on a basement floor of Palaceside Building in Takebashi, Tokyo)

https://www.mai-b.co.jp/index-en.html

Language: English 

Organizers: J-Stories/Pacific Bridge Media and Consulting; Mainichi Future Creation Lab

Focus Categories (Expected) :

CONTACT:
PACIFIC BRIDGE MEDIA AND CONSULTING
Editorial department:Toshi Maeda (Executive Editor)・Takanori Isshiki (Deputy Executive Editor)・Anita De Michele (Editorial Coordinator)
Email:info@pacificbridge.jp
Phone:+81- 50-5527-0955

** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **

Japan Global Innovators' Forum 2025

Japan Global Innovators' Forum 2025

Recommended Articles